Komori
Tsubota Laboratory (4890) · RiskRestated

Risks Related to the Relationship with the Department of Ophthalmology at Keio University School of Medicine and Shared Intellectual Property

First written in FY2023. 2 of 3 entries say "Restated". Latest entry: FY2026.

3entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2023 – FY20262023: 120232024: 120242025: 020252026: 12026
Same theme, other companies
Risks of Conflicts of Interest and Reputational Damage Associated with Industry-Academia CollaborationA theme 4 companies write about · 4 as a headwind · 0 as a tailwind

3 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「In addition to conducting research internally, the company conducts joint research with the Department of Ophthalmology, Keio University School of Medicine, and jointly owns patent rights and other intellectual property.」

    The company has reiterated the risks related to joint research, shared intellectual property and its relationship with contracted external researchers involving the Department of Ophthalmology, Keio University School of Medicine.
  2. FY2024RestatedAnnual report

    「In addition to conducting research internally, the company conducts joint research with the Department of Ophthalmology, Keio University School of Medicine, and jointly owns patent rights and other intellectual property.」

    The company has reiterated the risks related to joint research, shared intellectual property and the continuation of transactions with the Department of Ophthalmology, Keio University School of Medicine.
  3. FY2023First statedAnnual report

    「In addition to conducting research internally, the company conducts joint research with the Department of Ophthalmology, Keio University School of Medicine, and jointly owns patent rights and other intellectual property.」

    The company has identified as a new risk the potential impact if its joint research, jointly owned patents and relationship with Keio University, including contracted external researchers, cannot continue, or if transactions are suspected of constituting the provision of benefits.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Tsubota Laboratory yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risks Related to the Relationship with the Department of Ophthalmology at Keio University School of Medicine and Shared Intellectual Property | Tsubota Laboratory Incorporated (4890) | Komori